These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29246814)

  • 1. Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis.
    Karrasch M; Fingerle V; Boden K; Darr A; Baier M; Straube E; Nenadic I
    Ticks Tick Borne Dis; 2018 Feb; 9(2):415-417. PubMed ID: 29246814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
    Pietikäinen A; Oksi J; Hytönen J
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy.
    Eckman EA; Pacheco-Quinto J; Herdt AR; Halperin JJ
    Clin Infect Dis; 2018 Jun; 67(1):80-88. PubMed ID: 29340592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
    Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
    Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
    Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
    Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine CXCL13 in acute neuroborreliosis.
    Senel M; Rupprecht TA; Tumani H; Pfister HW; Ludolph AC; Brettschneider J
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):929-33. PubMed ID: 19965843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
    Rupprecht TA; Lechner C; Tumani H; Fingerle V
    Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland A
    J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH; Lager M; Henningsson AJ; Tjernberg I
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
    Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
    Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
    J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.
    Borde JP; Meier S; Fingerle V; Klier C; Hübner J; Kern WV
    BMC Infect Dis; 2012 Dec; 12():344. PubMed ID: 23228054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.
    van Burgel ND; Bakels F; Kroes AC; van Dam AP
    J Clin Microbiol; 2011 May; 49(5):2027-30. PubMed ID: 21367992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis: A Meta-Analysis.
    Yang J; Han X; Liu A; Bao F; Peng Y; Tao L; Ma M; Bai R; Dai X
    J Interferon Cytokine Res; 2017 Oct; 37(10):433-439. PubMed ID: 28972436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
    Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
    Tumani H; Cadavid D
    Neurology; 2011 Mar; 76(12):1034-5. PubMed ID: 21422454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.